IsoTech Design eNews, USP 797, sterile compounding, chemo/hazardous compounding, hormone compounding, environmental monitoring, aseptic filling, sterility testing, FDA, compounding pharmacies & centers, USP 795, cleaning and disinfecting, decontamination, sanitizing engineering controls & primary engineering controls
Nov. 21, 2013 ##EMAIL##, you've received this email because you're a valued customer of IsoTech Design. Archive
Home   About Us   Articles   Contact Us   Mobile version   Subscribe   Unsubscribe

Come see us at the ASHP Midyear Clinical Meeting in Orlando, Fla.!
IsoTech Design
Come see us at ASHP's Midyear Clinical Meeting in Orlando, Fla., Dec. 9-11. This meeting is the largest gathering of pharmacists in the world, attended by more than 20,000 pharmacists from around the world. This year's keynote speaker will also be Retired General Colin Powell, speaking on domestic and world affairs.

So, come out to sunny Orlando and don't forget to pay us a visit. We'll be at booth #1440 showing off our newest products, Clean Air Essentials 797! Clean Air Essentials offers everything needed for sterile and chemo compounding for USP 797 compliance.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Requirements and best practices for sanitizing engineering controls
Pharmacy Purchasing & Products
Poor cleaning practices are associated with microbial contamination of compounded sterile preparations, and consequently performing appropriate daily and monthly cleaning are vital to risk prevention. Though the professional literature contains an abundance of information detailing policies and procedures for cleaning sterile compounding primary and secondary engineering controls, much misunderstanding, misinterpretation and myth continues to surround this topic.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


FDA announces voluntary recall of certain sterile products from Specialty Medicine Compounding Pharmacy
U.S. Food and Drug Administration
The U.S. Food and Drug Administration is alerting hospitals, healthcare providers, veterinarians and patients of a voluntary recall of certain human and veterinary products produced and distributed for sterile use by Specialty Medicine Compounding Pharmacy of South Lyon, Mich.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Hospitals address compounding concerns
HealthLeaders Media
In the wake of incidents in which compounding pharmacies have released contaminated products, hospital leaders are developing strategies and protocols to ensure patient safety. It's a safe bet the fungal outbreak affecting patients who received contaminated steroid products prepared by the New England Compounding Center last fall has placed hospital leaders on a nervous edge, regardless of whether they were ever among that pharmacy's customers.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Achieving a good clean, inside and out
Laboratory Equipment
Earlier this year, a team of researchers from the National Institutes of Health announced they had identified a virus as a potential cause of hepatitis in their study of blood samples from 92 people from China who has serious cases of hepatitis not caused by any of the five already known viruses.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
 
MicroSphere M4 CAI

Complying with the USP 797 sterile compounding regulations for IV preparation, there are three basic options for contamination control: building a cleanroom, adding a compounding aseptic isolator or combining the two technologies. Each hospital or pharmacy have to determine the best strategy that makes the most sense based on cost, work flow volume, space and other considerations.


IsoTech Design eNews

IsoTech Design Inc.
1320 Graham Blvd, #120
Montreal, QC.
H3P 3C8
800-476-2010
info@isotechdesign.com

To unsubscribe, click here.

Did someone forward this edition to you?
Subscribe here -- it's free!